Cargando…

Modern mammography screening and breast cancer mortality: population study

Objective To evaluate the effectiveness of contemporary mammography screening using individual information about screening history and breast cancer mortality from public screening programmes. Design Prospective cohort study of Norwegian women who were followed between 1986 and 2009. Within that per...

Descripción completa

Detalles Bibliográficos
Autores principales: Weedon-Fekjær, Harald, Romundstad, Pål R, Vatten, Lars J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061379/
https://www.ncbi.nlm.nih.gov/pubmed/24951459
http://dx.doi.org/10.1136/bmj.g3701
_version_ 1782321485121060864
author Weedon-Fekjær, Harald
Romundstad, Pål R
Vatten, Lars J
author_facet Weedon-Fekjær, Harald
Romundstad, Pål R
Vatten, Lars J
author_sort Weedon-Fekjær, Harald
collection PubMed
description Objective To evaluate the effectiveness of contemporary mammography screening using individual information about screening history and breast cancer mortality from public screening programmes. Design Prospective cohort study of Norwegian women who were followed between 1986 and 2009. Within that period (1995-2005), a national mammography screening programme was gradually implemented, with biennial invitations sent to women aged 50-69 years. Participants All Norwegian women aged 50-79 between 1986 and 2009. Main outcome measures Multiple Poisson regression analysis was used to estimate breast cancer mortality rate ratios comparing women who were invited to screening (intention to screen) with women who were not invited, with a clear distinction between cases of breast cancer diagnosed before (without potential for screening effect) and after (with potential for screening effect) the first invitation for screening. We took competing causes of death into account by censoring women from further follow-up who died from other causes. Based on the observed mortality reduction combined with the all cause and breast cancer specific mortality in Norway in 2009, we used the CISNET (Cancer Intervention and Surveillance Modeling Network) Stanford simulation model to estimate how many women would need to be invited to biennial mammography screening in the age group 50-69 years to prevent one breast cancer death during their lifetime. Results During 15 193 034 person years of observation (1986-2009), deaths from breast cancer occurred in 1175 women with a diagnosis after being invited to screening and 8996 women who had not been invited before diagnosis. After adjustment for age, birth cohort, county of residence, and national trends in deaths from breast cancer, the mortality rate ratio associated with being invited to mammography screening was 0.72 (95% confidence interval 0.64 to 0.79). To prevent one death from breast cancer, 368 (95% confidence interval 266 to 508) women would need to be invited to screening. Conclusion Invitation to modern mammography screening may reduce deaths from breast cancer by about 28%.
format Online
Article
Text
id pubmed-4061379
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BMJ Publishing Group Ltd.
record_format MEDLINE/PubMed
spelling pubmed-40613792014-06-19 Modern mammography screening and breast cancer mortality: population study Weedon-Fekjær, Harald Romundstad, Pål R Vatten, Lars J BMJ Research Objective To evaluate the effectiveness of contemporary mammography screening using individual information about screening history and breast cancer mortality from public screening programmes. Design Prospective cohort study of Norwegian women who were followed between 1986 and 2009. Within that period (1995-2005), a national mammography screening programme was gradually implemented, with biennial invitations sent to women aged 50-69 years. Participants All Norwegian women aged 50-79 between 1986 and 2009. Main outcome measures Multiple Poisson regression analysis was used to estimate breast cancer mortality rate ratios comparing women who were invited to screening (intention to screen) with women who were not invited, with a clear distinction between cases of breast cancer diagnosed before (without potential for screening effect) and after (with potential for screening effect) the first invitation for screening. We took competing causes of death into account by censoring women from further follow-up who died from other causes. Based on the observed mortality reduction combined with the all cause and breast cancer specific mortality in Norway in 2009, we used the CISNET (Cancer Intervention and Surveillance Modeling Network) Stanford simulation model to estimate how many women would need to be invited to biennial mammography screening in the age group 50-69 years to prevent one breast cancer death during their lifetime. Results During 15 193 034 person years of observation (1986-2009), deaths from breast cancer occurred in 1175 women with a diagnosis after being invited to screening and 8996 women who had not been invited before diagnosis. After adjustment for age, birth cohort, county of residence, and national trends in deaths from breast cancer, the mortality rate ratio associated with being invited to mammography screening was 0.72 (95% confidence interval 0.64 to 0.79). To prevent one death from breast cancer, 368 (95% confidence interval 266 to 508) women would need to be invited to screening. Conclusion Invitation to modern mammography screening may reduce deaths from breast cancer by about 28%. BMJ Publishing Group Ltd. 2014-06-17 /pmc/articles/PMC4061379/ /pubmed/24951459 http://dx.doi.org/10.1136/bmj.g3701 Text en © Weedon-Fekjær et al 2014 http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/.
spellingShingle Research
Weedon-Fekjær, Harald
Romundstad, Pål R
Vatten, Lars J
Modern mammography screening and breast cancer mortality: population study
title Modern mammography screening and breast cancer mortality: population study
title_full Modern mammography screening and breast cancer mortality: population study
title_fullStr Modern mammography screening and breast cancer mortality: population study
title_full_unstemmed Modern mammography screening and breast cancer mortality: population study
title_short Modern mammography screening and breast cancer mortality: population study
title_sort modern mammography screening and breast cancer mortality: population study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061379/
https://www.ncbi.nlm.nih.gov/pubmed/24951459
http://dx.doi.org/10.1136/bmj.g3701
work_keys_str_mv AT weedonfekjærharald modernmammographyscreeningandbreastcancermortalitypopulationstudy
AT romundstadpalr modernmammographyscreeningandbreastcancermortalitypopulationstudy
AT vattenlarsj modernmammographyscreeningandbreastcancermortalitypopulationstudy